
Lycia Therapeutics Inc.
LYCAHealthcare|Biotechnology|US
$30.50
+1.70 (+5.90%)
Ownership Breakdown
16.5%
Float
52.1M
Shares Outstanding
8.6M
Float Shares
Major Holders (9)
Combined: 107.1%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Venrock Healthcare Capital Partners III, L.P. | Partnership | 11.90% | 6,850,237 | Oct 30, 2026 | 13D/G |
| VHCP Co-Investment Holdings III, LLC | Other | 11.90% | 6,850,237 | Oct 30, 2026 | 13D/G |
| Venrock Healthcare Capital Partners EG, L.P. | Partnership | 11.90% | 6,850,237 | Oct 30, 2026 | 13D/G |
| VHCP Management III, LLC | Other | 11.90% | 6,850,237 | Oct 30, 2026 | 13D/G |
| VHCP Management EG, LLC | Other | 11.90% | 6,850,237 | Oct 30, 2026 | 13D/G |
| Venrock Healthcare Capital Partners XP, L.P. | Partnership | 11.90% | 6,850,237 | Oct 30, 2026 | 13D/G |
| VHCP Management XP, LLC | Other | 11.90% | 6,850,237 | Oct 30, 2026 | 13D/G |
| Bong Y. Koh | Individual | 11.90% | 6,850,237 | Oct 30, 2026 | 13D/G |
| Nimish Shah | Individual | 11.90% | 6,850,237 | Oct 30, 2026 | 13D/G |
Insider Trades (59)
Last 4 quarters: 15,135,836 acquired · 53,225,676 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Venrock Healthcare Capital Partners III, L.P. | 10 percent owner | Nov 2, 2026 | BUY | 8,305 | $26.95 | $223.8K | Form 4 |
| Venrock Healthcare Capital Partners III, L.P. | 10 percent owner | Oct 30, 2026 | BUY | 200 | $26.86 | $5.4K | Form 4 |
| Venrock Healthcare Capital Partners III, L.P. | 10 percent owner | Oct 30, 2026 | BUY | 8,804 | $26.27 | $231.3K | Form 4 |
| Venrock Healthcare Capital Partners III, L.P. | 10 percent owner | Oct 29, 2026 | BUY | 1,000 | $26.33 | $26.3K | Form 4 |
| Venrock Healthcare Capital Partners III, L.P. | 10 percent owner | Oct 28, 2026 | BUY | 4,430 | $25.97 | $115.0K | Form 4 |
| Venrock Healthcare Capital Partners III, L.P. | 10 percent owner | Oct 28, 2026 | BUY | 10,570 | $25.23 | $266.7K | Form 4 |
| Versant Ventures VII GP, L.P. | 10 percent owner | Oct 26, 2026 | CONVERSION | 5,631,425 | — | — | Form 4 |
| Versant Ventures VII GP, L.P. | 10 percent owner | Oct 26, 2026 | CONVERSION | 1,393,882 | — | — | Form 4 |
| Versant Ventures VII GP, L.P. | 10 percent owner | Oct 26, 2026 | CONVERSION | 25,390,410 | — | — | Form 4 |
| Versant Ventures VII GP, L.P. | 10 percent owner | Oct 26, 2026 | CONVERSION | 6,284,597 | — | — | Form 4 |
| Venrock Healthcare Capital Partners III, L.P. | 10 percent owner | Oct 27, 2026 | BUY | 31,067 | $26.84 | $833.8K | Form 4 |
| Venrock Healthcare Capital Partners III, L.P. | 10 percent owner | Oct 27, 2026 | BUY | 8,729 | $25.84 | $225.6K | Form 4 |
| Venrock Healthcare Capital Partners III, L.P. | 10 percent owner | Oct 26, 2026 | BUY | 8,261 | $26.97 | $222.8K | Form 4 |
| Venrock Healthcare Capital Partners III, L.P. | 10 percent owner | Oct 26, 2026 | BUY | 1,944,444 | $18.00 | $35.0M | Form 4 |
| Venrock Healthcare Capital Partners III, L.P. | 10 percent owner | Oct 26, 2026 | CONVERSION | 4,779,793 | — | — | Form 4 |
| Venrock Healthcare Capital Partners III, L.P. | 10 percent owner | Oct 23, 2026 | BUY | 28,379 | $26.11 | $741.0K | Form 4 |
| Venrock Healthcare Capital Partners III, L.P. | 10 percent owner | Oct 23, 2026 | BUY | 24,560 | $25.68 | $630.7K | Form 4 |
| Venrock Healthcare Capital Partners III, L.P. | 10 percent owner | Oct 26, 2026 | CONVERSION | 17,142,578 | — | — | Form 4 |
| Venrock Healthcare Capital Partners III, L.P. | 10 percent owner | Oct 26, 2026 | CONVERSION | 4,408,091 | — | — | Form 4 |
| Fischer Laurent | director | Oct 22, 2026 | AWARD | 20,000 | $18.00 | $360.0K | Form 4 |
| Fischer Laurent | director | Aug 11, 2026 | AWARD | 13,307 | $3.70 | $49.2K | Form 4 |
| Henderson Jane | director | Aug 11, 2026 | AWARD | 57,666 | $3.70 | $213.4K | Form 4 |
| Henderson Jane | director | Oct 22, 2026 | AWARD | 20,000 | $18.00 | $360.0K | Form 4 |
| RIEFLIN WILLIAM JL | director | Aug 11, 2026 | AWARD | 24,840 | $3.70 | $91.9K | Form 4 |
| RIEFLIN WILLIAM JL | director | Oct 22, 2026 | AWARD | 20,000 | $18.00 | $360.0K | Form 4 |
| Touami Sofia | Chief Business Officer | Aug 11, 2026 | AWARD | 68,755 | $3.70 | $254.4K | Form 4 |
| Staben Steven | 10 percent owner, officer: Chief Scientific Officer | Aug 11, 2026 | AWARD | 110,896 | $3.70 | $410.3K | Form 4 |
| Lee Chin Hyok | 10 percent owner, officer: Chief Medical Officer | Aug 11, 2026 | AWARD | 73,191 | $3.70 | $270.8K | Form 4 |
| Bachrodt Amy | 10 percent owner, officer: Chief Financial Officer | Aug 11, 2026 | AWARD | 399,746 | $3.70 | $1.5M | Form 4 |
| Trombley Aetna Wun | director, 10 percent owner, officer: President and CEO | Aug 11, 2026 | AWARD | 443,586 | $3.70 | $1.6M | Form 4 |
| ELI LILLY & Co | 10 percent owner | Oct 22, 2026 | OTHER | 0 | — | — | Form 4 |
| Venrock Healthcare Capital Partners III, L.P. | 10 percent owner | Oct 22, 2026 | OTHER | 3,802,108 | — | — | Form 4 |
| Venrock Healthcare Capital Partners III, L.P. | 10 percent owner | Oct 22, 2026 | OTHER | 977,685 | — | — | Form 4 |
| Bertozzi Carolyn R | 10 percent owner | Oct 22, 2026 | OTHER | 0 | — | — | Form 4 |
| Henderson Jane | director | Oct 22, 2026 | OTHER | 57,666 | $3.70 | $213.4K | Form 4 |
| Versant Ventures VII GP, L.P. | 10 percent owner | Oct 22, 2026 | OTHER | 25,390,410 | — | — | Form 4 |
| Versant Ventures VII GP, L.P. | 10 percent owner | Oct 22, 2026 | OTHER | 6,284,597 | — | — | Form 4 |
| Fischer Laurent | director | Oct 22, 2026 | OTHER | 0 | — | — | Form 4 |
| Fischer Laurent | director | Oct 22, 2026 | OTHER | 13,307 | $2.44 | $32.5K | Form 4 |
| Fischer Laurent | director | Oct 22, 2026 | OTHER | 13,307 | $3.70 | $49.2K | Form 4 |
| RIEFLIN WILLIAM JL | director | Oct 22, 2026 | OTHER | 0 | — | — | Form 4 |
| RIEFLIN WILLIAM JL | director | Oct 22, 2026 | OTHER | 34,377 | $2.44 | $83.9K | Form 4 |
| RIEFLIN WILLIAM JL | director | Oct 22, 2026 | OTHER | 24,840 | $3.70 | $91.9K | Form 4 |
| Touami Sofia | Chief Business Officer | Oct 22, 2026 | OTHER | 169,228 | $1.67 | $282.6K | Form 4 |
| Touami Sofia | Chief Business Officer | Oct 22, 2026 | OTHER | 94,262 | $2.44 | $230.0K | Form 4 |
| Touami Sofia | Chief Business Officer | Oct 22, 2026 | OTHER | 68,755 | $3.70 | $254.4K | Form 4 |
| Staben Steven | 10 percent owner, officer: Chief Scientific Officer | Oct 22, 2026 | OTHER | 0 | — | — | Form 4 |
| Staben Steven | 10 percent owner, officer: Chief Scientific Officer | Oct 22, 2026 | OTHER | 166,345 | $1.63 | $271.1K | Form 4 |
| Staben Steven | 10 percent owner, officer: Chief Scientific Officer | Oct 22, 2026 | OTHER | 155,255 | $2.44 | $378.8K | Form 4 |
| Staben Steven | 10 percent owner, officer: Chief Scientific Officer | Oct 22, 2026 | OTHER | 22,179 | $2.35 | $52.1K | Form 4 |
| Staben Steven | 10 percent owner, officer: Chief Scientific Officer | Oct 22, 2026 | OTHER | 110,896 | $3.70 | $410.3K | Form 4 |
| Lee Chin Hyok | 10 percent owner, officer: Chief Medical Officer | Oct 22, 2026 | OTHER | 366,402 | $2.44 | $894.0K | Form 4 |
| Lee Chin Hyok | 10 percent owner, officer: Chief Medical Officer | Oct 22, 2026 | OTHER | 73,191 | $3.70 | $270.8K | Form 4 |
| Bachrodt Amy | 10 percent owner, officer: Chief Financial Officer | Oct 22, 2026 | OTHER | 399,746 | $3.70 | $1.5M | Form 4 |
| Trombley Aetna Wun | director, 10 percent owner, officer: President and CEO | Oct 22, 2026 | OTHER | 0 | — | — | Form 4 |
| Trombley Aetna Wun | director, 10 percent owner, officer: President and CEO | Oct 22, 2026 | OTHER | 471,252 | $1.63 | $768.1K | Form 4 |
| Trombley Aetna Wun | director, 10 percent owner, officer: President and CEO | Oct 22, 2026 | OTHER | 665,380 | $2.44 | $1.6M | Form 4 |
| Trombley Aetna Wun | director, 10 percent owner, officer: President and CEO | Oct 22, 2026 | OTHER | 55,448 | $2.35 | $130.3K | Form 4 |
| Trombley Aetna Wun | director, 10 percent owner, officer: President and CEO | Oct 22, 2026 | OTHER | 443,586 | $3.70 | $1.6M | Form 4 |